Industry Valuation and Performance
Has the Indonesian Pharma Industry valuation changed over the past few years?
Date Market Cap Revenue Earnings PE Tue, 05 Jul 2022 Rp106.6t Rp66.7t Rp5.2t 14.4x Thu, 02 Jun 2022 Rp110.7t Rp66.2t Rp5.2t 21.8x Sat, 30 Apr 2022 Rp109.5t Rp64.8t Rp5.1t 21.8x Mon, 28 Mar 2022 Rp114.4t Rp63.2t Rp5.1t 24.3x Wed, 23 Feb 2022 Rp116.0t Rp63.2t Rp5.1t 24.5x Fri, 21 Jan 2022 Rp118.9t Rp63.2t Rp5.1t 24.6x Sun, 19 Dec 2021 Rp118.0t Rp63.1t Rp5.1t 24.7x Tue, 16 Nov 2021 Rp114.7t Rp60.3t Rp4.4t 25x Thu, 14 Oct 2021 Rp106.4t Rp58.5t Rp4.3t 21.1x Sat, 11 Sep 2021 Rp107.9t Rp57.5t Rp4.3t 23.1x Mon, 09 Aug 2021 Rp98.1t Rp57.5t Rp4.3t 20.4x Sun, 02 May 2021 Rp108.5t Rp56.1t Rp4.1t 24.3x Wed, 03 Feb 2021 Rp113.0t Rp55.7t Rp4.0t 22.1x Sat, 07 Nov 2020 Rp118.2t Rp54.4t Rp3.9t 19.1x Fri, 31 Jul 2020 Rp105.1t Rp48.8t Rp3.7t 15.7x Mon, 04 May 2020 Rp88.2t Rp49.5t Rp3.6t 9.9x Thu, 06 Feb 2020 Rp85.5t Rp48.3t Rp3.5t 11x Sun, 10 Nov 2019 Rp105.0t Rp47.7t Rp3.7t 12.2x Sat, 03 Aug 2019 Rp106.3t Rp47.1t Rp3.7t 14x Median PE Ratio
Sat, 03 Aug 2019 Total Market Cap: Rp106.3t Total Earnings: Rp3.7t Total Revenue: Rp47.1t Total Market Cap vs Earnings and Revenue 0% 0% 0% Indonesian Pharma Industry Median PE 3Y Average 18.2x 2020 2021 2022 Current Industry PE Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically. The industry is trading at a PE ratio of 20.4x which is lower than its 3-year average PE of 26.0x. The industry's 3-year average PS ratio 1.9x is higher than the industry's current PS ratio of 1.6x. Past Earnings Growth The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years. Revenues for these companies have grown 12% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too. Industry Comparison
How does Indonesian Pharma compare with similar industries?
ID Market -4.66% Healthcare -1.57% Pharma -3.63% Pharma -3.63% Industry PEThere is insufficient data on the sub-industries of this industry. Forecasted GrowthThere is insufficient data on the sub-industries of this industry. Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
Simply Wall St ™ Simply Wall Street Pty Ltd 17-21 Bellevue Street, Surry Hills, Sydney
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.